ExodusPoint Capital Management, LP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1736225 NEW YORK, NY

Position in VRDN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$6,462,428

+$3,577,698 QoQ

Shares Held

330,390

+256.4% QoQ

Ownership

0.321%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $375,055,315 across 144 Biotechnology names. VRDN ranks #16 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	178,779	$33,798,169
2	INSM	INSMED Inc	148,133	$24,222,708
3	IONS	Ionis Pharmaceuticals Inc	227,084	$17,051,737
4	ABVX	Abivax S.A.	140,262	$15,618,173
5	COGT	Cogent Biosciences, Inc.	372,175	$14,325,015
6	VERA	Vera Therapeutics, Inc.	317,351	$12,767,030
7	BHVN	Biohaven Ltd.	1,501,099	$12,699,297
8	XENE	Xenon Pharmaceuticals Inc.	173,425	$10,084,663

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,462,428	330,390	+256.4%	Shares	Sole	2026-05-14
2025-12-31	$2,884,730	92,697	+543.1%	Shares	Sole	2026-02-17
2025-09-30	$311,032	14,413	-44.0%	Shares	Sole	2025-11-14
2024-12-31	$493,129	25,724	-56.3%	Shares	Sole	2025-02-12
2023-12-31	$1,282,907	58,903	-66.3%	Shares	Sole	2024-02-14
2023-09-30	$2,678,686	174,621	-15.7%	Shares	Sole	2023-11-13
2023-06-30	$4,929,549	207,211	+63.3%	Shares	Sole	2023-08-11
2023-03-31	$3,228,361	126,901	-33.4%	Shares	Sole	2023-05-11
2022-12-31	$5,569,003	190,654	+75.0%	Shares	Sole	2023-02-13
2022-09-30	$2,234,933	108,968	+11.5%	Shares	Sole	2022-11-10
2022-03-31	$1,807,305	97,745	+27.3%	Shares	Sole	2022-05-13
2021-12-31	$1,517,485	76,757	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.